Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:17387741rdf:typepubmed:Citationlld:pubmed
pubmed-article:17387741lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C1556094lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C0034802lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C0007131lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C0026882lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C2698872lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C1122962lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C0017256lld:lifeskim
pubmed-article:17387741lifeskim:mentionsumls-concept:C0683941lld:lifeskim
pubmed-article:17387741pubmed:issue9lld:pubmed
pubmed-article:17387741pubmed:dateCreated2007-5-24lld:pubmed
pubmed-article:17387741pubmed:abstractTextBecause the investigation of epidermal growth factor receptor gene (EGFR) status as a predictor of gefitinib efficacy in Japanese patients has shown promise, the authors evaluated EGFR mutations and gene amplification in biopsy specimens from Japanese patients with nonsmall cell lung cancer (NSCLC) who received treatment with gefitinib to analyze the correlation between EGFR gene status and clinical outcome.lld:pubmed
pubmed-article:17387741pubmed:languageenglld:pubmed
pubmed-article:17387741pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17387741pubmed:citationSubsetAIMlld:pubmed
pubmed-article:17387741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17387741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17387741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17387741pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:17387741pubmed:statusMEDLINElld:pubmed
pubmed-article:17387741pubmed:monthMaylld:pubmed
pubmed-article:17387741pubmed:issn0008-543Xlld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:FujimuraMasak...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:NakatsumiYasu...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:NishioKazutoKlld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:KasaharaKazuo...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:NakaoShinjiSlld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:ShibataKazuhi...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:MizuguchiMasa...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:KimuraHidehar...lld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:WasedaYukoYlld:pubmed
pubmed-article:17387741pubmed:authorpubmed-author:SoneTakashiTlld:pubmed
pubmed-article:17387741pubmed:copyrightInfoCopyright (c) 2007 American Cancer Societylld:pubmed
pubmed-article:17387741pubmed:issnTypePrintlld:pubmed
pubmed-article:17387741pubmed:day1lld:pubmed
pubmed-article:17387741pubmed:volume109lld:pubmed
pubmed-article:17387741pubmed:ownerNLMlld:pubmed
pubmed-article:17387741pubmed:authorsCompleteYlld:pubmed
pubmed-article:17387741pubmed:pagination1836-44lld:pubmed
pubmed-article:17387741pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:meshHeadingpubmed-meshheading:17387741...lld:pubmed
pubmed-article:17387741pubmed:year2007lld:pubmed
pubmed-article:17387741pubmed:articleTitleComparative analysis of epidermal growth factor receptor mutations and gene amplification as predictors of gefitinib efficacy in Japanese patients with nonsmall cell lung cancer.lld:pubmed
pubmed-article:17387741pubmed:affiliationRespiratory Medicine, School of Medicine, Kanazawa University, Kanazawa, and Shien-Lab, National Cancer Center Hospital, Tokyo, Japan.lld:pubmed
pubmed-article:17387741pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17387741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17387741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17387741lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:17387741lld:pubmed